Yongtao Han Selected Research

Yongtao Han Research Topics

Disease

28	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2018
18	Neoplasms (Cancer) 01/2024 - 06/2015
15	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 09/2014
9	Thymoma (Thymic Carcinoma) 01/2018 - 06/2015
8	Carcinoma (Carcinomatosis) 12/2023 - 09/2015
6	Thymus Neoplasms (Thymus Neoplasm) 07/2016 - 04/2016
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023 - 01/2018
5	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2007
5	Myasthenia Gravis 12/2018 - 04/2016
4	Neoplasm Metastasis (Metastasis) 05/2024 - 11/2021
4	Lymphatic Metastasis 12/2023 - 12/2021
1	Recurrent Laryngeal Nerve Injuries 12/2023
1	Vocal Cord Paralysis 12/2023
1	Circulating Neoplastic Cells 11/2023
1	Pain (Aches) 08/2023
1	Deglutition Disorders (Dysphagia) 08/2023
1	Fatigue 08/2023
1	Pathologic Constriction (Stenosis) 08/2023
1	Margins of Excision 11/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2021
1	Pathologic Complete Response 12/2021
1	Plasmacytoma 11/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Hypernatremia 01/2020
1	Hyponatremia 01/2020
1	Human Influenza (Influenza) 08/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2019
1	Infections 03/2019
1	Coronary Disease (Coronary Heart Disease) 03/2019
1	Diabetes Mellitus 03/2019
1	Leukopenia 01/2018
1	Neutropenia 01/2018
1	Postoperative Pain 11/2015
1	Wounds and Injuries (Trauma) 09/2015
1	Melanoma (Melanoma, Malignant) 08/2015
1	Chronic Hepatitis B 08/2015

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 05/2023 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 01/2022
3	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 05/2023 - 12/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 08/2019 - 06/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023
1	C-Reactive ProteinIBA 11/2023
1	Ferritins (Ferritin)IBA 11/2023
1	AlbuminsIBA 11/2023
1	trans-sodium crocetinate (crocetin)IBA 08/2023
1	NivolumabIBA 02/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	tislelizumabIBA 01/2022
1	usnic acidIBA 01/2022
1	vulpinic acidIBA 01/2022
1	toripalimabIBA 01/2022
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2021
1	LuciferasesIBA 01/2020
1	SodiumIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 06/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 06/2019
1	Minichromosome Maintenance Complex Component 4IBA 06/2019
1	Polo-Like Kinase 1IBA 06/2019
1	Cyclin-Dependent Kinase Inhibitor p57IBA 06/2019
1	cdc25 PhosphatasesIBA 06/2019
1	AntacidsIBA 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	Viral DNAIBA 08/2015
1	CytokinesIBA 08/2015
1	Interleukin-18 (Interleukin 18)IBA 08/2015
1	InflammasomesIBA 08/2015
1	belinostatIBA 06/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Cetuximab (Erbitux)FDA Link 06/2015
1	Immunoglobulin G (IgG)IBA 06/2015
1	Monoclonal AntibodiesIBA 06/2015
1	Gefitinib (Iressa)FDA Link 06/2015
1	Sorafenib (BAY 43-9006)FDA Link 06/2015
1	Sunitinib (Sutent)FDA Link 06/2015
1	Tyrosine Kinase InhibitorsIBA 06/2015
1	Insulin-Like PeptidesIBA 06/2015
1	cixutumumabIBA 06/2015
1	hexaconazoleIBA 03/2013

Therapy/Procedure

26	Neoadjuvant Therapy 01/2024 - 04/2016
14	Therapeutics 01/2023 - 02/2007
13	Esophagectomy 05/2024 - 09/2014
9	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 09/2014
9	Drug Therapy (Chemotherapy) 02/2023 - 04/2016
7	Radiotherapy 05/2024 - 04/2016
5	Thymectomy 12/2018 - 04/2016
4	Immunotherapy 01/2023 - 01/2022
3	Chemoradiotherapy 05/2024 - 01/2018
3	Adjuvant Radiotherapy 11/2021 - 12/2018
2	Thoracotomy 12/2021 - 12/2021
2	Adjuvant Chemotherapy 05/2020 - 12/2018
2	Length of Stay 11/2015 - 09/2015
1	Transplantation 01/2023
1	Adjuvant Chemoradiotherapy 05/2020
1	Minimally Invasive Surgical Procedures 12/2018
1	Operative Time 11/2015